Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
174 hedge funds and large institutions have $1.14B invested in Natus Medical Inc in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 62 increasing their positions, 60 reducing their positions, and 26 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
3% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 60
1% less capital invested
Capital invested by funds: $1.15B → $1.14B (-$7.92M)
8% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 26
1% less funds holding
Funds holding: 176 → 174 (-2)
88% less call options, than puts
Call options by funds: $2.13M | Put options by funds: $18M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$32.5M |
| 2 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
+$25.1M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$8.82M |
| 4 |
BlackRock
New York
|
+$5.77M |
| 5 |
Janus Henderson Group
London,
|
+$5.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$8.4M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$7.73M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.91M |
| 4 |
VCM
Voce Capital Management
San Francisco,
California
|
-$5.37M |
| 5 |
Impax Asset Management Group
London,
United Kingdom
|
-$4.05M |
NTUS Hedge Fund Activity: Q4 2018 in Review
174 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2018, worth a combined $1.14B — down 0.69% from $1.15B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of NTUS and 24 opened new positions — a net loss of 2 holders — while 60 trimmed existing stakes and 62 added.
The largest buyer was Vaughan Nelson Investment Management, opening a new position worth an estimated $32.5M. The largest seller was Peregrine Capital Management, exiting entirely with an estimated $8.4M sold.
- 174 institutional investors held Natus Medical Inc (NTUS) as of Q4 2018, down from 176 in Q3 2018.
- Funds reported $1.14B of Natus Medical Inc stock for Q4 2018, down 0.69% quarter-over-quarter.
- 24 funds opened new Natus Medical Inc positions in Q4 2018 and 26 closed out, a net change of -2 holders.
- The largest Natus Medical Inc buyer in Q4 2018 was Vaughan Nelson Investment Management, an estimated $32.5M added.
- The largest Natus Medical Inc seller in Q4 2018 was Peregrine Capital Management, an estimated $8.4M sold.
Based on aggregated 13F filings for Q4 2018.